Health Care Services

Viemed Healthcare

Viemed Healthcare released FY2026 Q1 earnings on May 5 During-Market (EST), actual revenue USD 75.41 M (forecast USD 74.4 M), actual EPS USD 0.06 (forecast USD 0.09)

Viemed Healthcare to Release FY2026 Q1 Earnings on May 6 During-Market EST, Forecast Revenue USD 74.4 M, EPS USD 0.09

Viemed Healthcare released FY2025 annual earnings on March 4 During-Market (EST), actual revenue USD 270.28 M (forecast USD 272 M), actual EPS USD 0.37 (forecast USD 0.3966)

Viemed Healthcare released FY2025 Q4 earnings on March 4 During-Market (EST), actual revenue USD 76.18 M (forecast USD 77.7 M), actual EPS USD 0.1408 (forecast USD 0.125)

Viemed Healthcare to Release FY2025 Earnings on March 5 During-Market (EST), Forecast Revenue USD 272M, EPS USD 0.3966

Viemed Healthcare released FY2025 Q3 earnings on November 5 During-Market EST, actual revenue USD 71.91 M (forecast USD 72 M), actual EPS USD 0.0899 (forecast USD 0.095)

Viemed Healthcare released FY2025 9 Months Earnings on November 5 During-Market EST, with actual revenue of USD 194.1 M and EPS of USD 0.2298

Viemed Healthcare to Release FY2025 Q3 Earnings on November 6 During-Market EST, Forecast Revenue USD 72M, EPS USD 0.09

Viemed Healthcare released FY2025 Semi-Annual earnings on August 6 During-Market (EST), actual revenue USD 122.19 M, actual EPS USD 0.1399

Viemed Healthcare released FY2025 Q2 earnings on August 6 During-Market (EST), actual revenue USD 63.06 M (forecast USD 63.5 M), actual EPS USD 0.0798 (forecast USD 0.09)

Viemed Healthcare to Release FY2025 Q2 Earnings on August 7 During-Market EST, Forecast Revenue USD 63.5 M, EPS USD 0.09

Viemed Healthcare Inc. Acquires Lehan's Medical Equipment

Michael Moore Disposes of Viemed Healthcare Shares

Nitin Kaushal Disposes of Viemed Healthcare Common Stock

Viemed Healthcare Authorizes Stock Repurchase Program

Viemed Holds Annual Shareholder Meeting and Approves Multiple Resolutions

Viemed Healthcare released FY2025 Q1 earnings on May 7 During-Market EST, actual revenue USD 59.13 M (forecast USD 60.6 M), actual EPS USD 0.06 (forecast USD 0.06)

Viemed Announces Acquisition of Lehan’s Medical Equipment

Viemed Healthcare to release FY2025 Q1 earnings report on May 8 During-Market EST, forecast revenue USD 60.6 M, EPS USD 0.06

JPMorgan Increases Stake in Viemed Healthcare

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26 | VMD Stock News

StockTitan

Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26 | VMD Stock News

Viemed Healthcare (NASDAQ:VMD) reported Q1 2026 revenue of $75.4 million, a 28% increase year-over-year, driven by strong performance in sleep and maternal health segments. The company improved free cash flow to $2.6 million, up from negative $5.7 million last year. Management raised 2026 revenue guidance to $312-$320 million, reflecting confidence in growth. The sleep business saw a 57% increase in PAP therapy patients, contributing to a stable growth profile. Viemed continues to execute its share repurchase program and has effectively no net debt, maintaining a strong financial position.

benzinga_article

Viemed Healthcare Q1 2026 Earnings Call: Complete Transcript

Earnings Watch

Viemed Healthcare | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 75.41 M

VensureHR has launched the Pathway to Care and Wellness program, aimed at helping employees make informed healthcare decisions and reduce out-of-pocket costs. This complimentary program for Vensure clients provides personalized support through experienced Benefits Advisors, guiding employees to optimal care options. Recognized with a Gold Stevie® Award, the program addresses the complexities of the healthcare system, offering services like Medicare transition support, COBRA optimization, and telemedicine education. CEO Alex Campos emphasizes that the initiative not only aids employees but also stabilizes healthcare costs for employers.

prnewswire

09:02 ETVensureHR Launches New Benefits Advisor Program to Reduce Out-of-Pocket Healthcare Costs

Shares of Viemed Healthcare Inc. (VMD) reached a 52-week high of $10.10 during intraday trading, reflecting the company's strong financial performance and growth potential. Viemed specializes in home medical equipment and post-acute healthcare services, offering advanced technologies for effective in-home treatment, including home ventilation and oxygen concentrators. This makes Viemed a noteworthy long-term investment opportunity.

rttnews

What's Powering Viemed's Next Chapter?

METCB

METC

UXIN

The U.S. market has seen a 30% increase over the past year, with earnings expected to grow by 16% annually. Growth companies with high insider ownership are appealing, indicating strong internal confidence. Notable companies include Uxin (35.7% insider ownership, 74.1% earnings growth), Ramaco Resources (10.4% insider ownership, 93.4% earnings growth), and Viemed Healthcare (13.6% insider ownership, 27.8% earnings growth). These companies show potential for growth despite varying challenges, with insider ownership aligning management interests with shareholders.

Simplywall

Ramaco Resources

Ramaco - CL

Uxin

Upstart

Precigen

Karman

Enovix

Clene

Caledonia Mining

Better Home & Finance

Astera Labs

AppLovin

CLENE INC C/WTS 30/12/2025 (TO PUR COM)

BETTER HOME & FINANCE HOLDING C/WTS 22/08/2028(TO PUR COM)

RAMACO RESOURCES INC 8.25% NTS 31/07/2030 USD25

RAMACO RESOURCES INC 8.375% SENIR FXD NT DUE 30/11/2029 USD25

Ramaco Resources Pref share METCL 9 07/30/26

Three Insider-Favored Growth Companies With High Ownership

Viemed Healthcare (NASDAQ:VMD) is set to release its Q1 2026 earnings on May 5, with analysts predicting earnings of $0.09 per share and revenue of $74.40 million. The company previously reported $0.14 earnings per share for Q4 2025, exceeding estimates. The stock has seen a slight increase, trading at $9.94. Recent insider trading includes President Michael Moore selling 65,000 shares. Institutional investors hold 74.24% of the stock, indicating strong interest. Viemed specializes in home-based respiratory therapy services, focusing on long-term mechanical ventilation and pulmonary support.

Market Beat

NASDAQ Composite Index

Invesco

MetLife

METLIFE INC PRF SERIE 'A' FLOATING RATE USD25

METLIFE INC 4.75% DEP SHS EA REP NN CUM PFD ST SER F

METLIFE INC 5.625% NON CUM PRD STK SER E

Viemed Healthcare (VMD) to Release Quarterly Earnings on Tuesday

Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details | VMD Stock News

Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details | VMD Stock News

Viemed Healthcare(VMD.US)

Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26 | VMD Stock News

Viemed Healthcare Q1 2026 Earnings Call: Complete Transcript

Viemed Healthcare | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 75.41 M

09:02 ETVensureHR Launches New Benefits Advisor Program to Reduce Out-of-Pocket Healthcare Costs

What's Powering Viemed's Next Chapter?

Three Insider-Favored Growth Companies With High Ownership

Viemed Healthcare (VMD) to Release Quarterly Earnings on Tuesday

Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details | VMD Stock News